Determination of phenotypes predicting complications in COVID-19 and evaluation of the efficacy of immunosuppressive treatments (INMUNOSUPR COVID-19) First published 07/04/2020 Last updated 14/03/2024 EU PAS number:EUPAS34607 Study Finalised